{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:42:45Z","timestamp":1777426965290,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,29]]},"DOI":"10.7759\/cureus.20014","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T21:18:19Z","timestamp":1638220699000},"source":"Crossref","is-referenced-by-count":4,"title":["Induced Native Phage Therapy for the Treatment of Lyme Disease and Relapsing Fever: A Retrospective Review of First 14 Months in One Clinic"],"prefix":"10.7759","author":[{"given":"David A","family":"Jernigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keeley K","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Jameson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Farney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00055","article-title":"Borrelia miyamotoi: 43 cases diagnosed in France by real-time PCR in patients with persistent polymorphic signs and symptoms","volume":"7","author":"Franck M","year":"2020","unstructured":"Franck M, Ghozzi R, Pajaud J, Lawson-Hogban NE, Mas M, Lacout A, Perronne C. Borrelia miyamotoi: 43 cases diagnosed in France by real-time PCR in patients with persistent polymorphic signs and symptoms. Front Med (Lausanne). 2020, 7:55. 10.3389\/fmed.2020.00055","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9120868","article-title":"\"Repurposing\" disulfiram in the treatment of Lyme disease and babesiosis: retrospective review of first 3 years' experience in one medical practice","volume":"9","author":"Gao J","year":"2020","unstructured":"Gao J, Gong Z, Montesano D, Glazer E, Liegner K. \"Repurposing\" disulfiram in the treatment of Lyme disease and babesiosis: retrospective review of first 3 years' experience in one medical practice. Antibiotics (Basel). 2020, 9:868. 10.3390\/antibiotics9120868","journal-title":"Antibiotics (Basel)"},{"key":"ref3","article-title":"Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencephalomyelitides","volume":"4","author":"Liegner K","year":"1997","unstructured":"Liegner K, Duray P, Agricola M, et al.. Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencephalomyelitides. J Spirochetal Tick Borne Dis. 1997, 4:61-73.","journal-title":"J Spirochetal Tick Borne Dis"},{"key":"ref4","article-title":"It ain\u2019t just one thing","author":"Kaufman D","year":"2020","unstructured":"Kaufman D, Ruhoy I. It ain\u2019t just one thing.  ILADS Annual Conference 2020. ILADS, Bethesda, MD; 2020."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11166","article-title":"Pulsed electromagnetic field with temozolomide can elicit an epigenetic pro-apoptotic effect on glioblastoma T98G cells","volume":"36","author":"Pasi F","year":"2016","unstructured":"Pasi F, Fassina L, Mognaschi ME, Lupo G, Corbella F, Nano R, Capelli E. Pulsed electromagnetic field with temozolomide can elicit an epigenetic pro-apoptotic effect on glioblastoma T98G cells. Anticancer Res. 2016, 36:5821-6. 10.21873\/anticanres.11166","journal-title":"Anticancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-11-20","article-title":"Studies of inactivation mechanism of non-enveloped icosahedral virus by a visible ultrashort pulsed laser","volume":"11","author":"Tsen SW","year":"2014","unstructured":"Tsen SW, Kingsley DH, Poweleit C, Achilefu S, Soroka DS, Wu TC, Tsen KT. Studies of inactivation mechanism of non-enveloped icosahedral virus by a visible ultrashort pulsed laser. Virol J. 2014, 11:20. 10.1186\/1743-422X-11-20","journal-title":"Virol J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.657524","article-title":"Differential bacteriophage efficacy in controlling Salmonella in cattle hide and soil models","volume":"12","author":"Xie Y","year":"2021","unstructured":"Xie Y, Thompson T, O'Leary C, Crosby S, Nguyen QX, Liu M, Gill JJ. Differential bacteriophage efficacy in controlling Salmonella in cattle hide and soil models. Front Microbiol. 2021, 12:657524. 10.3389\/fmicb.2021.657524","journal-title":"Front Microbiol"},{"key":"ref8","article-title":"Bacteriophages","author":"Kasman LM","year":"2021","unstructured":"Kasman LM, Porter LD. Bacteriophages. StatPearls, Treasure Island, FL; 2021."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsre.2003.08.001","article-title":"Ecology of prokaryotic viruses","volume":"28","author":"Weinbauer MG","year":"2004","unstructured":"Weinbauer MG. Ecology of prokaryotic viruses. FEMS Microbiol Rev. 2004, 28:127-81. 10.1016\/j.femsre.2003.08.001","journal-title":"FEMS Microbiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/v13091734","article-title":"Examining the effects of an anti-Salmonella bacteriophage preparation, BAFASAL\u00ae, on ex-vivo human gut microbiome composition and function using a multi-omics approach","volume":"13","author":"Mayne J","year":"2021","unstructured":"Mayne J, Zhang X, Butcher J, et al.. Examining the effects of an anti-Salmonella bacteriophage preparation, BAFASAL\u00ae, on ex-vivo human gut microbiome composition and function using a multi-omics approach. Viruses. 2021, 13:1734. 10.3390\/v13091734","journal-title":"Viruses"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.05.009","article-title":"Close encounters of three kinds: bacteriophages, commensal bacteria, and host immunity","volume":"26","author":"Keen EC","year":"2018","unstructured":"Keen EC, Dantas G. Close encounters of three kinds: bacteriophages, commensal bacteria, and host immunity. Trends Microbiol. 2018, 26:943-54. 10.1016\/j.tim.2018.05.009","journal-title":"Trends Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.651217","article-title":"Targeting multicopy prophage genes for the increased detection of Borrelia burgdorferi sensu lato (s.l.), the causative agents of Lyme disease, in blood","volume":"12","author":"Shan J","year":"2021","unstructured":"Shan J, Jia Y, Teuli\u00e8res L, Patel F, Clokie MR. Targeting multicopy prophage genes for the increased detection of Borrelia burgdorferi sensu lato (s.l.), the causative agents of Lyme disease, in blood. Front Microbiol. 2021, 12:651217. 10.3389\/fmicb.2021.651217","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy614","article-title":"Direct diagnostic tests for Lyme disease","volume":"68","author":"Schutzer SE","year":"2019","unstructured":"Schutzer SE, Body BA, Boyle J, et al.. Direct diagnostic tests for Lyme disease. Clin Infect Dis. 2019, 68:1052-7. 10.1093\/cid\/ciy614","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-92808-1_9","article-title":"DNA looping in prophage lambda: new insight from single-molecule microscopy","author":"Finzi L","year":"2011","unstructured":"Finzi L, Manzo C, Zurla C, Wang H, Lewis D, Adhya S, Dunlap D. DNA looping in prophage lambda: new insight from single-molecule microscopy. Biophysics of DNA-Protein Interactions: From Single Molecules to Biological Systems. Williams MC, Maher LJ (ed): Springer, New York, NY; 2011. 193-212. 10.1007\/978-0-387-92808-1_9"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4161\/bact.1.2.15845","article-title":"Phage treatment of human infections","volume":"1","author":"Abedon ST","year":"2011","unstructured":"Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage. 2011, 1:66-85. 10.4161\/bact.1.2.15845","journal-title":"Bacteriophage"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/138920108785161604","article-title":"The use of phages for the removal of infectious biofilms","volume":"9","author":"Azeredo J","year":"2008","unstructured":"Azeredo J, Sutherland IW. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol. 2008, 9:261-6. 10.2174\/138920108785161604","journal-title":"Curr Pharm Biotechnol"},{"key":"ref17","article-title":"Exposure to a 50 Hz electromagnetic field induces activation of the Epstein-Barr virus genome in latently infected human lymphoid cells","volume":"16","author":"Grimaldi S","year":"1997","unstructured":"Grimaldi S, Pasquali E, Barbatano L, Lisi A, Santoro N, Serafino A, Pozzi D. Exposure to a 50 Hz electromagnetic field induces activation of the Epstein-Barr virus genome in latently infected human lymphoid cells. J Environ Pathol Toxicol Oncol. 1997, 16:205-7.","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2015.00048","article-title":"Epigenetics and animal virus infections","volume":"6","author":"Galvan SC","year":"2015","unstructured":"Galvan SC, Garc\u00eda Carranc\u00e1 A, Song J, Recillas-Targa F. Epigenetics and animal virus infections. Front Genet. 2015, 6:48. 10.3389\/fgene.2015.00048","journal-title":"Front Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/v9110346","article-title":"Epigenetic regulation of viral biological processes","volume":"9","author":"Balakrishnan L","year":"2017","unstructured":"Balakrishnan L, Milavetz B. Epigenetic regulation of viral biological processes. Viruses. 2017, 9:346. 10.3390\/v9110346","journal-title":"Viruses"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2009.04.009","article-title":"Signal amplification in biological and electrical engineering systems: universal role of cascades","volume":"143","author":"Grubelnik V","year":"2009","unstructured":"Grubelnik V, Dugonik B, Osebik D, Marhl M. Signal amplification in biological and electrical engineering systems: universal role of cascades. Biophys Chem. 2009, 143:132-8. 10.1016\/j.bpc.2009.04.009","journal-title":"Biophys Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.013.10177","article-title":"Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies","volume":"32","author":"Zimmerman JW","year":"2013","unstructured":"Zimmerman JW, Jimenez H, Pennison MJ, et al.. Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Chin J Cancer. 2013, 32:573-81. 10.5732\/cjc.013.10177","journal-title":"Chin J Cancer"},{"key":"ref22","article-title":"Illuminated physiology and medical uses of light","volume":"16","author":"Jernigan D","year":"2009","unstructured":"Jernigan D, Joseph S. Illuminated physiology and medical uses of light. Subtle Energies Energy Med. 2009, 16:251-69.","journal-title":"Subtle Energies Energy Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu703","article-title":"A comparison of Lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment","volume":"59","author":"Fallon BA","year":"2014","unstructured":"Fallon BA, Pavlicova M, Coffino SW, Brenner C. A comparison of Lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment. Clin Infect Dis. 2014, 59:1705-10. 10.1093\/cid\/ciu703","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.02.005","article-title":"Laboratory diagnosis of Lyme disease: advances and challenges","volume":"29","author":"Marques AR","year":"2015","unstructured":"Marques AR. Laboratory diagnosis of Lyme disease: advances and challenges. Infect Dis Clin North Am. 2015, 29:295-307. 10.1016\/j.idc.2015.02.005","journal-title":"Infect Dis Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00057","article-title":"Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease","volume":"7","author":"Rebman AW","year":"2020","unstructured":"Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front Med (Lausanne). 2020, 7:57. 10.3389\/fmed.2020.00057","journal-title":"Front Med (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2021.02.002","article-title":"Targeting biofilms using phages and their enzymes","volume":"68","author":"Azeredo J","year":"2021","unstructured":"Azeredo J, Garc\u00eda P, Drulis-Kawa Z. Targeting biofilms using phages and their enzymes. Curr Opin Biotechnol. 2021, 68:251-61. 10.1016\/j.copbio.2021.02.002","journal-title":"Curr Opin Biotechnol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.03.018","article-title":"Coevolution between bacterial CRISPR-Cas systems and their bacteriophages","volume":"29","author":"Watson BN","year":"2021","unstructured":"Watson BN, Steens JA, Staals RH, Westra ER, van Houte S. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages. Cell Host Microbe. 2021, 29:715-25. 10.1016\/j.chom.2021.03.018","journal-title":"Cell Host Microbe"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00326","article-title":"Defeating antibiotic- and phage-resistant Enterococcus faecalis using a phage cocktail in vitro and in a clot model","volume":"9","author":"Khalifa L","year":"2018","unstructured":"Khalifa L, Gelman D, Shlezinger M, Dessal AL, Coppenhagen-Glazer S, Beyth N, Hazan R. Defeating antibiotic- and phage-resistant Enterococcus faecalis using a phage cocktail in vitro and in a clot model. Front Microbiol. 2018, 9:326. 10.3389\/fmicb.2018.00326","journal-title":"Front Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01039-07","article-title":"Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes","volume":"76","author":"Cruz AR","year":"2008","unstructured":"Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, Radolf JD. Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect Immun. 2008, 76:56-70. 10.1128\/IAI.01039-07","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/37551","article-title":"Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi","volume":"390","author":"Fraser CM","year":"1997","unstructured":"Fraser CM, Casjens S, Huang WM, et al.. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature. 1997, 390:580-6. 10.1038\/37551","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1128\/iai.55.9.2311-2313.1987","article-title":"Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi","volume":"55","author":"Takayama K","year":"1987","unstructured":"Takayama K, Rothenberg RJ, Barbour AG. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun. 1987, 55:2311-3. 10.1128\/iai.55.9.2311-2313.1987","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0434","article-title":"The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis","volume":"96","author":"Butler T","year":"2017","unstructured":"Butler T. The Jarisch-Herxheimer reaction after antibiotic treatment of spirochetal infections: a review of recent cases and our understanding of pathogenesis. Am J Trop Med Hyg. 2017, 96:46-52. 10.4269\/ajtmh.16-0434","journal-title":"Am J Trop Med Hyg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.3.1107-1115.1999","article-title":"Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release","volume":"67","author":"Talkington J","year":"1999","unstructured":"Talkington J, Nickell SP. Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release. Infect Immun. 1999, 67:1107-15. 10.1128\/IAI.67.3.1107-1115.1999","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making","volume":"26","author":"Berger ML","year":"2017","unstructured":"Berger ML, Sox H, Willke RJ, et al.. Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Pharmacoepidemiol Drug Saf. 2017, 26:1033-9. 10.1002\/pds.4297","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2217\/pme.11.7","article-title":"The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?","volume":"8","author":"Lillie EO","year":"2011","unstructured":"Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?. Per Med. 2011, 8:161-73. 10.2217\/pme.11.7","journal-title":"Per Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01352","article-title":"More is better: selecting for broad host range bacteriophages","volume":"7","author":"Ross A","year":"2016","unstructured":"Ross A, Ward S, Hyman P. More is better: selecting for broad host range bacteriophages. Front Microbiol. 2016, 7:1352. 10.3389\/fmicb.2016.01352","journal-title":"Front Microbiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02552-16","article-title":"Multistrain infections with Lyme Borreliosis pathogens in the tick vector","volume":"83","author":"Durand J","year":"2017","unstructured":"Durand J, Herrmann C, Genn\u00e9 D, Sarr A, Gern L, Voordouw MJ. Multistrain infections with Lyme Borreliosis pathogens in the tick vector. Appl Environ Microbiol. 2017, 83:e02552-16. 10.1128\/AEM.02552-16","journal-title":"Appl Environ Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00725.x","article-title":"A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group","volume":"13","author":"Guo JJ","year":"2010","unstructured":"Guo JJ, Pandey S, Doyle J, Bian B, Lis Y, Raisch DW. A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. Value Health. 2010, 13:657-66. 10.1111\/j.1524-4733.2010.00725.x","journal-title":"Value Health"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/nature17193","article-title":"Lytic to temperate switching of viral communities","volume":"531","author":"Knowles B","year":"2016","unstructured":"Knowles B, Silveira CB, Bailey BA, et al.. Lytic to temperate switching of viral communities. Nature. 2016, 531:466-70. 10.1038\/nature17193","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin DM","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017, 8:162-73. 10.4292\/wjgpt.v8.i3.162","journal-title":"World J Gastrointest Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76183-induced-native-phage-therapy-for-the-treatment-of-lyme-disease-and-relapsing-fever-a-retrospective-review-of-first-14-months-in-one-clinic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:21Z","timestamp":1707507141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76183-induced-native-phage-therapy-for-the-treatment-of-lyme-disease-and-relapsing-fever-a-retrospective-review-of-first-14-months-in-one-clinic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.20014","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,29]]}}}